Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Ballen

Showing results (91-100 of 164) with videos related to

Pageof 17
Sort By:
Leukemia Research|June 24, 2011
Outcome of older adults with cytogenetically normal AML (CN-AML) and FLT3 mutationsHarshabad Singh, Salma Asali, Lillian L Werner, et al.
Bone Marrow Transplantation|October 9, 2012
Expression of α4β7 integrin on memory CD8(+) T cells at the presentation of acute intestinal GVHDY-B Chen, S McDonough, H Chen, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 11, 2013
Risk factors for invasive fungal disease after allogeneic hematopoietic stem cell transplantation: a single center experienceAazim K Omer, Panayiotis D Ziakas, Theodora Anagnostou, et al.
British Journal of Haematology|April 12, 2000
Effect of ex vivo cytokine treatment on human cord blood engraftment in NOD-scid miceK Ballen, P S Becker, D Greiner, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 14, 2009
Busulfan and cyclophosphamide (Bu/Cy) as a preparative regimen for autologous stem cell transplantation in patients with non-Hodgkin lymphoma: a single-institution experienceMatthew Ulrickson, Julie Aldridge, Haesook T Kim, et al.
Leukemia Research|June 19, 2013
Phase I dose escalation study of bortezomib in combination with lenalidomide in patients with myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML)Eyal C Attar, Philip C Amrein, James W Fraser, et al.
Experimental Hematology|June 26, 2007
Regulatory T-cell recovery in recipients of haploidentical nonmyeloablative hematopoietic cell transplantation with a humanized anti-CD2 mAb, MEDI-507, with or without fludarabineJuanita Shaffer, Jean Villard, Terry K Means, et al.
The New England Journal of Medicine|September 2, 2011
Cord colitis syndrome in cord-blood stem-cell transplantationAlex F Herrera, Gabriela Soriano, Andrew M Bellizzi, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|May 26, 2017
A multicenter, retrospective, case-cohort study of the epidemiology and risk factors for Clostridium difficile infection among cord blood transplant recipientsCarolyn D Alonso, David A Braun, Ishan Patel, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 16, 2007
Double unrelated reduced-intensity umbilical cord blood transplantation in adultsKaren K Ballen, Thomas R Spitzer, Beow Y Yeap, et al.
Pageof 17

Showing results (91-100 of 164) with videos related to

Sort By:
Pageof 17
Leukemia Research|June 24, 2011
Outcome of older adults with cytogenetically normal AML (CN-AML) and FLT3 mutationsHarshabad Singh, Salma Asali, Lillian L Werner, et al.
Bone Marrow Transplantation|October 9, 2012
Expression of α4β7 integrin on memory CD8(+) T cells at the presentation of acute intestinal GVHDY-B Chen, S McDonough, H Chen, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 11, 2013
Risk factors for invasive fungal disease after allogeneic hematopoietic stem cell transplantation: a single center experienceAazim K Omer, Panayiotis D Ziakas, Theodora Anagnostou, et al.
British Journal of Haematology|April 12, 2000
Effect of ex vivo cytokine treatment on human cord blood engraftment in NOD-scid miceK Ballen, P S Becker, D Greiner, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 14, 2009
Busulfan and cyclophosphamide (Bu/Cy) as a preparative regimen for autologous stem cell transplantation in patients with non-Hodgkin lymphoma: a single-institution experienceMatthew Ulrickson, Julie Aldridge, Haesook T Kim, et al.
Leukemia Research|June 19, 2013
Phase I dose escalation study of bortezomib in combination with lenalidomide in patients with myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML)Eyal C Attar, Philip C Amrein, James W Fraser, et al.
Experimental Hematology|June 26, 2007
Regulatory T-cell recovery in recipients of haploidentical nonmyeloablative hematopoietic cell transplantation with a humanized anti-CD2 mAb, MEDI-507, with or without fludarabineJuanita Shaffer, Jean Villard, Terry K Means, et al.
The New England Journal of Medicine|September 2, 2011
Cord colitis syndrome in cord-blood stem-cell transplantationAlex F Herrera, Gabriela Soriano, Andrew M Bellizzi, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|May 26, 2017
A multicenter, retrospective, case-cohort study of the epidemiology and risk factors for Clostridium difficile infection among cord blood transplant recipientsCarolyn D Alonso, David A Braun, Ishan Patel, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 16, 2007
Double unrelated reduced-intensity umbilical cord blood transplantation in adultsKaren K Ballen, Thomas R Spitzer, Beow Y Yeap, et al.
Pageof 17